Why the study?
To investigate the relationship between mortality and morbidity of phosphorylcholine-coated oxygenator circuits used in congenital open heart surgery operations.
Does a phosphorylcholine coated oxygenator circuit reduce morbidity and mortality in congenital heart patients undergoing open heart surgery?
Does a phosphorylcholine coated oxygenator circuit reduce morbidity and mortality in congenital heart patients undergoing open heart surgery?
Phosphorylcholine-coated oxygenator circuits may improve hemocompatibility and reduce discharge time in congenital open heart surgery, though they do not significantly reduce the overall inflammatory response.
No takes yet. Share an insight, caveat, or question.
No morbidity or mortality benefit; leaves open whether phosphorylcholine coating improves outcomes in congenital heart surgery.
BOLAT et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: